Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg
NCT00650416
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Carvedilol Tablets 12.5 mg
DRUG:
Coreg® Tablets 12.5 mg
Sponsor
Mylan Pharmaceuticals Inc